![David Licata](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van David Licata
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
1200 Pharma LLC
![]() 1200 Pharma LLC Pharmaceuticals: MajorHealth Technology 1200 Pharma LLC engages in the provision of pre-clinical drug discovery and clinical approval timelines. The company is headquartered in Pasadena, CA. | Algemeen Directeur | 01-11-2017 | - |
TORL Biotherapeutics LLC
![]() TORL Biotherapeutics LLC BiotechnologyHealth Technology TORL Biotherapeutics LLC is a clinical-stage biopharmaceutical company based in Culver City, CA. TORL Biotherapeutics LLC is focused on developing new antibodies, including monoclonal antibodies (mAbs) and drug conjugates (ADCs), to transform the lives of patients with various types of cancer. TORL has a strategic partnership with the Slamon Research Lab and has exclusive rights to a program of biologics-based drugs for novel cancer targets. The company's lead program, TORL-1-23, is an ADC directed towards cldn6 for patients with multiple cancers. In addition to this, TORL has four other clinical-stage antibody programs and is building a pipeline of novel ADCs and mAbs for cancers with high unmet medical needs. The company was founded by David Licata, and the CEO is Mark J. Alles. | Oprichter | - | - |
Financieel Directeur/CFO | 09-01-2024 | - | |
President | 09-01-2024 | - | |
Algemeen Directeur | - | 09-01-2024 |
Loopbaan van David Licata
Statistieken
Internationaal
Verenigde Staten | 3 |
Operationeel
Chief Executive Officer | 2 |
Director of Finance/CFO | 1 |
Founder | 1 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
1200 Pharma LLC
![]() 1200 Pharma LLC Pharmaceuticals: MajorHealth Technology 1200 Pharma LLC engages in the provision of pre-clinical drug discovery and clinical approval timelines. The company is headquartered in Pasadena, CA. | Health Technology |
TORL Biotherapeutics LLC
![]() TORL Biotherapeutics LLC BiotechnologyHealth Technology TORL Biotherapeutics LLC is a clinical-stage biopharmaceutical company based in Culver City, CA. TORL Biotherapeutics LLC is focused on developing new antibodies, including monoclonal antibodies (mAbs) and drug conjugates (ADCs), to transform the lives of patients with various types of cancer. TORL has a strategic partnership with the Slamon Research Lab and has exclusive rights to a program of biologics-based drugs for novel cancer targets. The company's lead program, TORL-1-23, is an ADC directed towards cldn6 for patients with multiple cancers. In addition to this, TORL has four other clinical-stage antibody programs and is building a pipeline of novel ADCs and mAbs for cancers with high unmet medical needs. The company was founded by David Licata, and the CEO is Mark J. Alles. | Health Technology |
- Beurs
- Insiders
- David Licata
- Ervaring